The global Oligo Synthesis market size was valued at US$ 663 million in 2024 and is forecast to a readjusted size of USD 1370 million by 2031 with a CAGR of 11.3% during review period.
Oligo synthesis, also known as oligonucleotide synthesis, is a laboratory technique used to chemically synthesize short sequences of nucleic acids, typically DNA or RNA oligonucleotides. These oligonucleotides are composed of relatively short chains of nucleotides, usually less than 100 bases in length. Oligos (or oligonucleotides) are commonly used as primers in PCR (polymerase chain reactions) to selectively amplify target DNA sequences. They can be tagged with fluorescent dyes or radioisotopes for detection purposes. Oligos are often used in DNA sequencing, gene synthesis, and genetic testing, and can be modified for gene therapies or gene expression.
Global key players of Oligo Synthesis include Thermo Fisher Scientific, Merck, Genscript, BBI Life Sciences, Integrated DNA Technologies (IDT), etc. The top five players hold a share about 44%. North America is the largest market, and has a share about 53%, followed by Asia-Pacific and Europe with share 25% and 15%, separately. In terms of product type, Common Primer Synthesis is the largest segment, occupied for a share of 64%. In terms of end user, Biotech Company has a share about 75 percent.
This report is a detailed and comprehensive analysis for global Oligo Synthesis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oligo Synthesis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oligo Synthesis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oligo Synthesis market size and forecasts, by Type and by End User, in consumption value ($ Million), 2020-2031
Global Oligo Synthesis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligo Synthesis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligo Synthesis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Azenta Life Sciences, BBI Life Sciences, TriLink BioTechnologies, Aurigene Pharmaceutical Services, Integrated DNA Technologies (IDT), Cusabio, Macrogen, Synbio Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Oligo Synthesis market is split by Type and by End User. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Common Primer Synthesis
Modified Primer Synthesis
麻豆原创 segment by End User
Biotech Company
Academic Scientific Research Institution
麻豆原创 segment by players, this report covers
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oligo Synthesis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligo Synthesis, with revenue, gross margin, and global market share of Oligo Synthesis from 2020 to 2025.
Chapter 3, the Oligo Synthesis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oligo Synthesis market forecast, by regions, by Type and by End User, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligo Synthesis.
Chapter 13, to describe Oligo Synthesis research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Oligo Synthesis by Type
1.3.1 Overview: Global Oligo Synthesis 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oligo Synthesis Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Common Primer Synthesis
1.3.4 Modified Primer Synthesis
1.4 Global Oligo Synthesis 麻豆原创 by End User
1.4.1 Overview: Global Oligo Synthesis 麻豆原创 Size by End User: 2020 Versus 2024 Versus 2031
1.4.2 Biotech Company
1.4.3 Academic Scientific Research Institution
1.5 Global Oligo Synthesis 麻豆原创 Size & Forecast
1.6 Global Oligo Synthesis 麻豆原创 Size and Forecast by Region
1.6.1 Global Oligo Synthesis 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oligo Synthesis 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Oligo Synthesis 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Oligo Synthesis 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oligo Synthesis 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Oligo Synthesis 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oligo Synthesis 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Oligo Synthesis Product and Solutions
2.1.4 Thermo Fisher Scientific Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Oligo Synthesis Product and Solutions
2.2.4 Merck Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Merck Recent Developments and Future Plans
2.3 Azenta Life Sciences
2.3.1 Azenta Life Sciences Details
2.3.2 Azenta Life Sciences Major Business
2.3.3 Azenta Life Sciences Oligo Synthesis Product and Solutions
2.3.4 Azenta Life Sciences Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Azenta Life Sciences Recent Developments and Future Plans
2.4 BBI Life Sciences
2.4.1 BBI Life Sciences Details
2.4.2 BBI Life Sciences Major Business
2.4.3 BBI Life Sciences Oligo Synthesis Product and Solutions
2.4.4 BBI Life Sciences Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 BBI Life Sciences Recent Developments and Future Plans
2.5 TriLink BioTechnologies
2.5.1 TriLink BioTechnologies Details
2.5.2 TriLink BioTechnologies Major Business
2.5.3 TriLink BioTechnologies Oligo Synthesis Product and Solutions
2.5.4 TriLink BioTechnologies Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 TriLink BioTechnologies Recent Developments and Future Plans
2.6 Aurigene Pharmaceutical Services
2.6.1 Aurigene Pharmaceutical Services Details
2.6.2 Aurigene Pharmaceutical Services Major Business
2.6.3 Aurigene Pharmaceutical Services Oligo Synthesis Product and Solutions
2.6.4 Aurigene Pharmaceutical Services Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
2.7 Integrated DNA Technologies (IDT)
2.7.1 Integrated DNA Technologies (IDT) Details
2.7.2 Integrated DNA Technologies (IDT) Major Business
2.7.3 Integrated DNA Technologies (IDT) Oligo Synthesis Product and Solutions
2.7.4 Integrated DNA Technologies (IDT) Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Integrated DNA Technologies (IDT) Recent Developments and Future Plans
2.8 Cusabio
2.8.1 Cusabio Details
2.8.2 Cusabio Major Business
2.8.3 Cusabio Oligo Synthesis Product and Solutions
2.8.4 Cusabio Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Cusabio Recent Developments and Future Plans
2.9 Macrogen
2.9.1 Macrogen Details
2.9.2 Macrogen Major Business
2.9.3 Macrogen Oligo Synthesis Product and Solutions
2.9.4 Macrogen Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Macrogen Recent Developments and Future Plans
2.10 Synbio Technologies
2.10.1 Synbio Technologies Details
2.10.2 Synbio Technologies Major Business
2.10.3 Synbio Technologies Oligo Synthesis Product and Solutions
2.10.4 Synbio Technologies Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Synbio Technologies Recent Developments and Future Plans
2.11 Eurogentec
2.11.1 Eurogentec Details
2.11.2 Eurogentec Major Business
2.11.3 Eurogentec Oligo Synthesis Product and Solutions
2.11.4 Eurogentec Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Eurogentec Recent Developments and Future Plans
2.12 Genscript
2.12.1 Genscript Details
2.12.2 Genscript Major Business
2.12.3 Genscript Oligo Synthesis Product and Solutions
2.12.4 Genscript Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Genscript Recent Developments and Future Plans
2.13 Abace Biotechnology
2.13.1 Abace Biotechnology Details
2.13.2 Abace Biotechnology Major Business
2.13.3 Abace Biotechnology Oligo Synthesis Product and Solutions
2.13.4 Abace Biotechnology Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Abace Biotechnology Recent Developments and Future Plans
2.14 Tsingke
2.14.1 Tsingke Details
2.14.2 Tsingke Major Business
2.14.3 Tsingke Oligo Synthesis Product and Solutions
2.14.4 Tsingke Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Tsingke Recent Developments and Future Plans
2.15 Guangzhou RiboBio
2.15.1 Guangzhou RiboBio Details
2.15.2 Guangzhou RiboBio Major Business
2.15.3 Guangzhou RiboBio Oligo Synthesis Product and Solutions
2.15.4 Guangzhou RiboBio Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Guangzhou RiboBio Recent Developments and Future Plans
2.16 Atantares
2.16.1 Atantares Details
2.16.2 Atantares Major Business
2.16.3 Atantares Oligo Synthesis Product and Solutions
2.16.4 Atantares Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Atantares Recent Developments and Future Plans
2.17 Wuhan GeneCreate Biological Engineering
2.17.1 Wuhan GeneCreate Biological Engineering Details
2.17.2 Wuhan GeneCreate Biological Engineering Major Business
2.17.3 Wuhan GeneCreate Biological Engineering Oligo Synthesis Product and Solutions
2.17.4 Wuhan GeneCreate Biological Engineering Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Wuhan GeneCreate Biological Engineering Recent Developments and Future Plans
2.18 Beyotime
2.18.1 Beyotime Details
2.18.2 Beyotime Major Business
2.18.3 Beyotime Oligo Synthesis Product and Solutions
2.18.4 Beyotime Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Beyotime Recent Developments and Future Plans
2.19 General Biol
2.19.1 General Biol Details
2.19.2 General Biol Major Business
2.19.3 General Biol Oligo Synthesis Product and Solutions
2.19.4 General Biol Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 General Biol Recent Developments and Future Plans
2.20 Biosune
2.20.1 Biosune Details
2.20.2 Biosune Major Business
2.20.3 Biosune Oligo Synthesis Product and Solutions
2.20.4 Biosune Oligo Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 Biosune Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Oligo Synthesis Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Oligo Synthesis by Company Revenue
3.2.2 Top 3 Oligo Synthesis Players 麻豆原创 Share in 2024
3.2.3 Top 6 Oligo Synthesis Players 麻豆原创 Share in 2024
3.3 Oligo Synthesis 麻豆原创: Overall Company Footprint Analysis
3.3.1 Oligo Synthesis 麻豆原创: Region Footprint
3.3.2 Oligo Synthesis 麻豆原创: Company Product Type Footprint
3.3.3 Oligo Synthesis 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Oligo Synthesis Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Oligo Synthesis 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by End User
5.1 Global Oligo Synthesis Consumption Value 麻豆原创 Share by End User (2020-2025)
5.2 Global Oligo Synthesis 麻豆原创 Forecast by End User (2026-2031)
6 North America
6.1 North America Oligo Synthesis Consumption Value by Type (2020-2031)
6.2 North America Oligo Synthesis 麻豆原创 Size by End User (2020-2031)
6.3 North America Oligo Synthesis 麻豆原创 Size by Country
6.3.1 North America Oligo Synthesis Consumption Value by Country (2020-2031)
6.3.2 United States Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Oligo Synthesis Consumption Value by Type (2020-2031)
7.2 Europe Oligo Synthesis Consumption Value by End User (2020-2031)
7.3 Europe Oligo Synthesis 麻豆原创 Size by Country
7.3.1 Europe Oligo Synthesis Consumption Value by Country (2020-2031)
7.3.2 Germany Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Oligo Synthesis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oligo Synthesis Consumption Value by End User (2020-2031)
8.3 Asia-Pacific Oligo Synthesis 麻豆原创 Size by Region
8.3.1 Asia-Pacific Oligo Synthesis Consumption Value by Region (2020-2031)
8.3.2 China Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Oligo Synthesis Consumption Value by Type (2020-2031)
9.2 South America Oligo Synthesis Consumption Value by End User (2020-2031)
9.3 South America Oligo Synthesis 麻豆原创 Size by Country
9.3.1 South America Oligo Synthesis Consumption Value by Country (2020-2031)
9.3.2 Brazil Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Oligo Synthesis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oligo Synthesis Consumption Value by End User (2020-2031)
10.3 Middle East & Africa Oligo Synthesis 麻豆原创 Size by Country
10.3.1 Middle East & Africa Oligo Synthesis Consumption Value by Country (2020-2031)
10.3.2 Turkey Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Oligo Synthesis 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Oligo Synthesis 麻豆原创 Drivers
11.2 Oligo Synthesis 麻豆原创 Restraints
11.3 Oligo Synthesis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Oligo Synthesis Industry Chain
12.2 Oligo Synthesis Upstream Analysis
12.3 Oligo Synthesis Midstream Analysis
12.4 Oligo Synthesis Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune
听
听
*If Applicable.
